ARCHIVES

Risk of Relapse Continues After Five Years of Therapy

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

NCI-Approved Clinical Trials

September 29, 2006

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985